My clinical interest is currently in the field of cancer genetics and cancer prevention. Previously my research focus was on the language used in recruiting underserved minorities into clinical trials, their attitudes toward these studies, and how these may impact their participation. Through my translational laboratory research in Her2 overexpressing breast cancer, I also have a keen interest in cell signaling, especially downstream of oncogenic Ras and Her2/Neu. I would like to examine the relative effects and efficacy of targeted agents on various ethnic populations with epithelial cancers. Learning more about this would be extremely beneficial in better tailoring our treatments for these individuals.